FDA warning letter drives nationwide chemo drug shortage

American Health Intel

Rules · Money · Medicine · Decoded daily

FDA warning letter drives nationwide chemo drug shortage

Plus: 23 states sue HHS over new Title X family planning conditions. The day's rules, money, and enforcement, sourced and tiered below.

Record

An FDA warning letter to a German drug plant, after inspectors found contamination dozens of times in two years, is now driving a nationwide shortage of a chemotherapy drug used to treat bone, soft tissue, and lymphoma cancers.

Alternate manufacturers are rationing supply through allocation and can't meet full demand. Pediatric oncologists say the shortage may not ease until October, forcing them to ration doses mid-treatment.

Record

Twenty-three states, led by New York's Attorney General, are suing HHS, the federal health department, over new Title X family planning grant conditions they say illegally punish clinics that serve transgender patients.

The new rules require clinics to exclude transgender patients, push natural family planning over contraception, and counsel toward marriage, without the public comment process federal law requires. NY alone gets $11.1M a year.

Also today

CMS proposes retroactive Medicare enrollment revocations nationwide Read
Dallas clinic pays $7.5M for phantom COVID testing visit billing Read
Rhode Island AG fights 22% health insurance rate hike Read

Pick your field on the site and every story tells you what it means for you.

Reply to this email and tell us what you want covered. We read everything.

We show our work. We score our own calls.

Track record · Calendar · Enforcement · X · LinkedIn

News and analysis, not legal, medical, coding, or investment advice.
You subscribed at americanhealthintel.com · Unsubscribe